Creative Medical Technologies Has Received A Notice Of Allowance For A U.S. Patent Titled "SUPPRESSION OF DIABETES USING EXOSOMES FROM STEM CELL PROGRAMMED MYELOID CELLS"
https://x.com/PatentGrants/status/2085092646184497356https://patentcenter.uspto.gov/applications/17931868/ifw/docs
Creative Medical got official approval from the U.S. government to be the only company allowed to make a specific diabetes treatment using special cells. This shows the company is working on real science, but approval from the government doesn't mean the treatment will definitely work or make money yet.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.